Surgical management of unusual presentation of axillary lymphoma: a case-based approach

Authors

  • Sangita Motiram Gavit Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India
  • Kiran Vitthal Sondge Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India
  • Sunil Dnyaneshwar Gutte Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-2902.isj20251917

Keywords:

Hodgkin’s lymphoma, Axillary lymphadenopathy, Excisional biopsy, Reed-Sternberg cells, Surgical management

Abstract

Axillary lymphadenopathy has a broad differential, from benign causes to malignancies like lymphoma. Hodgkin’s lymphoma (HL), a hematologic cancer, may present atypically, complicating diagnosis. This case highlights a rare presentation of HL, stressing the value of surgical excision biopsy for definitive diagnosis. A 32-year-old female presented with a gradually enlarging, painless right axillary mass (5×5 cm) over six months, accompanied by B symptoms. Examination revealed firm, nodular lymphadenopathy localized to right axilla. Imaging (USG and HRCT) suggested malignancy; however, FNAC was inconclusive due to inadequate architecture for Reed-Sternberg (RS) cell identification. Excision biopsy confirmed HL (Nodular sclerosis subtype). Immunohistochemistry (CD15 and CD30 positive) supported the diagnosis. Under general anaesthesia, complete excision was achieved via a transverse axillary crease incision, preserving neurovascular structures. Histopathology confirmed RS cells, establishing HL diagnosis. This case emphasizes diagnostic and therapeutic challenge of atypical axillary lymphadenopathy. FNAC limitations in lymphoma necessitate excisional biopsy as diagnostic gold standard. Integration of clinical, radiological, and pathological findings is vital for accurate diagnosis and management. This case demonstrates essential role of excisional biopsy in diagnosing atypical HL. Complete surgical removal enabled histopathological and immunohistochemical confirmation. Early diagnosis and a multidisciplinary strategy are key to better outcomes.

Metrics

Metrics Loading ...

Author Biographies

Sangita Motiram Gavit, Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India

Associate professor   
Institution: Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India

Sunil Dnyaneshwar Gutte, Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India

Resident    
Institution: Department of Surgery, Government Medical College, Jalgaon, MUHS, Nashik, Maharashtra, India

References

Johnson P, Wright D. Lymphadenopathy and Lymphomas: Overview of Diagnostic Challenges. Lancet Oncol. 2019;20(3):45-56.

Bray F, Mathieu L, Hyuna S, Jacques F, Rebecca LS, Isabelle S, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers. CA: A Cancer J Clin. 2020;70(1):1-41.

Siegel RL, Kimberly DM, Nikita SW, Ahmedin J. Cancer statistics, 2023. CA: A Cancer J Clin. 2023;73(1):1-33. DOI: https://doi.org/10.3322/caac.21763

Evens AM. Hodgkin lymphoma: A comprehensive review. Ann Oncol. 2022;33(2):189-200.

Pileri SA. Hodgkin lymphoma epidemiology and etiology. J Clin Oncol. 2016;34(1):17-25.

Castillo JJ. Epidemiology of non-Hodgkin lymphoma. Clin Lymphoma Myeloma Leukemia. 2019;19(5):33-50. DOI: https://doi.org/10.1016/j.clml.2019.07.269

Campo E. The 2017 WHO classification of lymphoid neoplasms. Blood. 2017;129(11):120-31.

Makarenko VV. Utility and Limitations of Fine-Needle Aspiration Cytology in the Diagnosis of Lymphadenopathy. J Pathol Translational Med. 2023;57(1):1-9.

Syrykh C, Chaouat C, Poullot E, Amara N, Fataccioli V, Parrens M, et al. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey. Blood. 2022;140(24):2573-83. DOI: https://doi.org/10.1182/blood.2022015520

Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease, 10th Edition. Elsevier, Chapter 13: The Hematopoietic and Lymphoid Systems. 2020;587-636.

ESMO Guidelines. Treatment of Hodgkin’s Lymphoma. Ann Oncol. 2022;33(4):456-67.

NCCN Guidelines. Hodgkin Lymphoma: Diagnosis and Management. National Comprehensive Cancer Network, Version 3. 2023.

Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress. CA Cancer J Clin. 2018;68(2):116-32. DOI: https://doi.org/10.3322/caac.21438

Johnson P. Advances in the treatment of Hodgkin lymphoma. Nature Rev Clin Oncol. 2021;18(3):123-35.

Kluwer W. B Symptoms in Lymphoma. UpToDate. 2023.

Colak E, Kucuk GO, Yildirim K, Ozturk O. The Diagnostic Value of Sonographic Findings in Axillary Lymphadenopathy. J Fam Med Health Care. 2015;1(2):21-3. DOI: https://doi.org/10.11648/j.jfmhc.20150102.11

Devaraj A, Chakrabarti I, Khandelwal A. High-Resolution CT of the Chest in Lymphoma: A Review of Imaging Features and Their Diagnostic Role. Indian J Radiol Imaging. 2016;26(2):123-9.

Sriram Bhat M. SRB’s Manual of Surgery 6th Edition chapter1 General surgery O. Lymphatics. 2015;239-57.

Di Micco R, Catanuto G, Di Micco B. Axillary lymphadenectomy: safe dissection through a correct technique. J Surgical Case Rep. 2023;2023(1):rjad001.

Downloads

Published

2025-06-25

How to Cite

Gavit, S. M., Sondge, K. V., & Gutte, S. D. (2025). Surgical management of unusual presentation of axillary lymphoma: a case-based approach. International Surgery Journal, 12(7), 1179–1184. https://doi.org/10.18203/2349-2902.isj20251917

Issue

Section

Case Reports